chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient c/o head ache, malaise, flu-like symptoms starting the morning after having received the vaccination and lasting for approximately 24 hours. Patient states that one week later she developed a raised, extremely itchy rash on her torso that lasted for three weeks.
(04/17/2021)  Flu-like symptoms lasted for a while and it came and went until was prescribed prednisone. However, when course was finished symptoms returned and PCP said to try and endure it. Fatigue and lack of appetite. Also, cyst removal.
PATIENT'S LT ARM BEGAN FEELING SORE AND REDNESS NOTED AROUND 12:00 P.M.LATER IN EVENING, PATIENT BEGAN HAVING CHILLS, FEVER AND LT ARM STILL NOTED RED. PATIENT STATES TOOK #2 BABY ASA LAST NIGHT @ 7:30 P.M. AND FEVER AND CHILLS SUBSIDED THIS A.M. PRESENTED TO CLINIC @ 3:30 P.M. WITH A 6" X 5" AREA TO LT ARM WITH LIGHT REDNESS,WARM TO TOUCH AND LOWER AREA RAISED.PATIENT C/O LT ARM STILL SORE SOMEWHAT.STATES WENT TO HEART DOCTOR EARLIER TODAY AND HE SENT HER TO THIS CLINIC FOR NURSE TO OBSERVE REACTION. ADVISED PATIENT TO RETURN HOME AND PLACE COOL COMPRESSES AND TAKE TYLENOL PRN.
Client reported that one week after vaccination,  her became red, swollen, painful, and hot. She went to ER and they diagnosed it as cellulitis and prescribed antibiotics.
pt recv vax & devel a inj site rxn characterized by redness, heat, soreness, & swelling from the shoulder to the elbow;
This case was reported by a consumer via call center representative and described the occurrence of sickness in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced sickness. On an unknown date, the outcome of the sickness was recovered/resolved. It was unknown if the reporter considered the sickness to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter reported that a friend told him that her doctor (patient) was very sick for several days after he received SHINGRIX.
Worst flu of his life without cough and runny nose; symptoms seems to be getting worse as the weeks pass; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of INFLUENZA (Worst flu of his life without cough and runny nose) and CONDITION AGGRAVATED (symptoms seems to be getting worse as the weeks pass) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-May-2021, the patient experienced INFLUENZA (Worst flu of his life without cough and runny nose) and CONDITION AGGRAVATED (symptoms seems to be getting worse as the weeks pass). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, INFLUENZA (Worst flu of his life without cough and runny nose) outcome was unknown and CONDITION AGGRAVATED (symptoms seems to be getting worse as the weeks pass) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-May-2021, Blood test: normal (normal) Other. On 17-May-2021, COVID-19: negative (Negative) Other. On 17-May-2021, Urine analysis: normal (normal) Other.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information also included: Cold meds (name unavailable).
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On an unknown date the patient was vaccinated with improperly stored ROTATEQ (lot # L013192, expiration date: 19-JAN-2017, dose and route were not reported). Concomitant drug was not reported. The vaccine had exposed to 32.4 F temperature for 2 hours and 15 minutes without previous temperature excursion. No adverse event was reported. This is one of the several reports from the same reporter. Additional information has been requested.
Systemic: Chills-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Hypertension-Mild, Systemic: Nausea-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Shakiness-Mild
Receive Pediatric (5-11) dose instead of 12+ dose at 15 years old by mistake.
Nausea, joint pain, muscle pain, dizziness, diarrhea, cold sweat, fatigue.
I did not eat before my appointment, and had taken 325mg of aspirin before the vaccine due to my chronic chest pain (undiagnosed).   My other meds were taken the night before. Approximately ten minutes after receiving the vaccine, I developed a metallic taste in my mouth.  After being observed for 45 minutes, I left and got something to eat.  After I ate the metallic taste lasted another hour before diminishing.
FATIGUE,JOINT PAIN; MUSCLE PAIN; HEADACHE; WARM RESOLVED 8AM NEXT DAY Narrative:
Patient reports to receiving only one vaccine in the primary sars-cov-2 series. Patient inadvertently received the bivalent vaccine without finishing primary series.  The patient's first dose in the series was given on 10/26/21. Patient states to not finishing the series due to being in labor around the time second dose was due.  Patient made aware that the patient was due for a monovalent sars-cov-2 vaccine and was ineligible to receive the bivalent booster as per the current recommendation by CDC and authorized by FDA. Patient monitored for 30 minutes in the clinic with no adverse events noted. Patient will continue to monitor at home and has an upcoming appointment to be seen in the clinic again.
Patient stated that he had a rash over his upper torso and inside his thighs, and his upper lip swelled. This was his second Shingrix shot given. He said it lasted into 3-4 days of taking loratadine.
Infant became limp, ?apneic, cyanotic hrs p/shots & shortly p/feeding w/o hx of choking/gasping; no sz noted but infant ? "postictal" behavior 5-10 min;
First shot 5/18/21, due to COVID no 2nd; This case was reported by a other health professional via interactive digital media and described the occurrence of social problem in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included shingles vaccine (1st dose received on 18th May 2021).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced social problem. On an unknown date, the outcome of the social problem was unknown.   It was unknown if the reporter considered the social problem to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not applicable to this report. The reporter gave the 1st shot of series and due to Covid and patient phone problems, the patient was now asking for the 2nd shot. The reporter asked GlaxoSmithKline what should he/she do. The follow-up would not possible as no contact details were available.
Started to get itchy; Small hives all over body; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Started to get itchy) and URTICARIA (Small hives all over body) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC), BUPROPION HYDROCHLORIDE (WELLBUTRIN) and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced PRURITUS (Started to get itchy) and URTICARIA (Small hives all over body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, PRURITUS (Started to get itchy) and URTICARIA (Small hives all over body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
At 8-9 pm pt c/o of headache, nausea, tingling in both arms and legs "felt weak and sore" and "dizzy". Woke up this AM and vomited. Denies any rash, throat tightness.
Information has been received from a consumer reporting on her 9-week-old male son who on 19-SEP-2007 was vaccinated with a dose of RECOMBIVAX HB (Lot # "1418F"). Concomitant vaccines administered on 19-SEP-2007 included ROTATEQ, Hib (MSD), DTP (manufacturer unspecified), poliovirus vaccine (manufacturer unspecified) and pneumococcal conj vaccine (manufacturer unspecified). On 20-SEP-2007 the patient experienced a "decrease in appetite" after vaccination. The patient sought unspecified medical attention. It was reported the patient's eating is not quite back to normal at the time of reporting. A product quality complaint was not involved. Follow-up information was received on 13-NOV-2007 and indicated the patient was seen during an office on 08-OCT-2007 (for follow-up) and his parents reported that his appetite was still not back to normal, but he appeared healthy and had not lost weight. Follow-up information received from a physician indicated a 9-week-old male received the following vaccines on 19-SEP-2007 at 09:30: first intramuscular dose of COMVAX (lot # 656270/1418F) administered in the right thigh (previously reported as RECOMBIVAX HB) (Lot # "1418F"); first intramuscular dose of DTaP (manufacturer Aventis) (lot # C2657AA) administered in the right thigh; first intramuscular dose of IPOL (lot # A0170) administered in the left thigh; first intramuscular dose PREVNAR (lot # 1354007E) administered in the left thigh and first oral dose of ROTATEQ (lot # 657660/0972U). Hib was deleted in follow-up. The physician reported that patient's mother stated on 20-SEP-2007 at 08:00 the patient had a very poor appetite for 3 weeks and the child did not lose any weight during this time. There were no illnesses at the time of vaccination. The patient did not have any pertinent medical history or allergies and no diagnostic labs were performed. On the 11-OCT-2007 (3 weeks later) the patient recovered. Additional information is not expected.
Pain in right shoulder several hours after vaccine administered, which was somewhat relieved with TYLENOL and ice pack to site. Swelling to right deltoid and shoulder anteriorly that is 2-3x size of normal.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 24Jun2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 57 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hashimoto hypo thyroidism" (unspecified if ongoing); "Penicillin" (unspecified if ongoing), notes: Known allergies: penicillin. Concomitant medication(s) included: LEVOTHYROXIN; STATIN EZ; METFORMIN. Past drug history included: Amoxocillinn, reaction(s): "Known allergies: Amoxocillinn".  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: The patient received other medication in 2 weeks was yes. The patient received COVID 19 treatment from 02Jul2022 to 07Jul2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
I experienced after my second dose, left side of my face and ear went numb and tingly. I  had funny taste to my stomach and felt nauseated.  I looked like Bell's palsy syndrome. I went to the ER, they gave me steroid medication.    I experienced after my first dose, I had numbness and tingling sensation on my left side of m face, had a metallic taste and when i would eat I would get nauseated, like I was going to throw up, my tongue felt funny, strange only on my left side. I had lob work done for my thyroid, I had  a Covid-19  test which was negative.  These symptoms lasted abut four days before my second dose.
I was so much pain, could not get out of bed, extremely exhausted. I went to the doctor where upon examination I was diagnosed with both an ear and sinus infection. I was given a prescription for Amoxicillin to help get the infection cleared within the seven-day course. In February, I ended up in the emergency room to have an emergency removal of my gall bladder. I did find out that I had a lot of gall stones in my body.
This spontaneous case reported by a consumer, describes the occurrence of rash (incredible rash for the past 10 days) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced rash (incredible rash for the past 10 days). At the time of the report, rash (incredible rash for the past 10 days) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported. Most recent follow-up information incorporated: On Jul 2, 2021: Follow-up received on Jul 2, 2021, event outcome updated from not recovered to recovered.
States that he feels like BP is elevated, VS obtained (BP 142/75, HR 88, RR 97%)    - felt better
patient sat for 15 minutes. after walking out of pharmacy and saying good bye, pt family called about 30-60 mins later stating that pt face drooping and possible tia/stroke. this was on 9/16/2020. vaccine giving around 4pm. reporting vaers today 9/17/2020. followed up with pt 9/17/2020 9am left message no answer.  pt was advised to call ambulance last night.
Patient felt week and fainted, came to without Epipen and was had nausea and vommiting and was very thirsty. Pale, EMt's called. Blood pressure was normal. She went home with mother. Mom said she has done this before with medical procedures, very anxious.
Started having pain in muscle of right arm would spread like I was having heart pain in chest. Can't work for more then 10 minutes without pain coming back.
Sore arm with moderate pain, felt tired, unusually severe joint and muscle pain, a bad headache, stomach pain, diarrhea, suspected fever, then few hours later, sweating, shivering (could not get warm) and insomnia as a result of the suspected fever/chills/sweating.
Itching in arm of injection; This case was reported by a pharmacist via call center representative and described the occurrence of itchy upper limbs in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number ZP3P9, expiry date 10th September 2021) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced itchy upper limbs. On an unknown date, the outcome of the itchy upper limbs was recovered/resolved.   It was unknown if the reporter considered the itchy upper limbs to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix on an unknown arm. The patient had itching in arm of injection for one week after receiving Shingrix.
I had the 2nd shot of Moderna vaccine Monday 5/3 at noon by 3 AM the next morning I had a fever measured 104.5 chills, headache, weak. I tool Tylenol as directed it would only reduce temps to 101 after 2 hours the fever 104 would return. This lasted until late morning the next day my temps started to fall off to 99. Tiredness and headaches still a problem been 3 days since the Moderna 2nd vaccine shot. I also feel some inner ear pressure like some inflammation in there.  The headaches seem to be getting somewhat worse causing me to feel nauseated I took 500 MG of Ibuprofen seems to reduce the headaches. I also developed a cough dry but almost like a flu cough which seems to be resolving.
tight feeling in his chest; nausea; dizziness; paresthesia in his hands, feet, and right arm; stinging and itching in his legs and right arm; stinging and itching in his legs and right arm; feeling sore and weak in his legs; feeling sore and weak in his legs; bad tension headaches; pain and tightness in his jaw; pain and tightness in his jaw; sore throat; feeling "flu-y" and feverish; groggy felling; body muscle aching; was tired; soreness at the injection site; This is a spontaneous report from a contactable consumer (patient). A 32-year-old male patient reported that received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unknown date as sin-gle dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced on the following Wednesday he experienced soreness at the injection site, feeling "flu-y" and feverish, had a "groggy feeling" and was tired, and had general "body muscle aching." He states that these symptoms lasted from Wednesday through Friday night, and then reports that on Saturday and Sunday he was fine. He then reports that on the 11th and the 12th (forgot to ask caller to specify month) he started experiencing a tight feeling in his chest, nausea, dizziness, paresthesia in his hands, feet, and right arm, stinging and itching in his legs and right arm, feeling sore and weak in his legs, bad tension headaches, pain and tightness in his jaw, and a sore throat. Caller wonders if these side effects are even related because he states he had the standard "expected" reaction, got better, then experienced these other things. Caller would like to know if he should get the second dose of the vaccine, which he is due for on Wednesday. Outcome of the events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
pt exp low grade fever, myalgias, stiffness & pain w/activity in the arm of inject, p/receiving vax; sx lasted somewhat more than 6 wks; PE revealed tenderness over the muscles of the upper & lower extremities;
Patient received dose #2 of Pfizer vaccine on 6/9/2021 and was notified by email that vial was left in freezer past recommended time frame. Email recommended patient get re-vaccinated with dose again. Physicians re-administered dose on 6/12/2021 as recommended. No adverse reactions identified on site.
Swelling/erythema right thigh.  Prescription cold compress. Resolved by prescription.
missing 3rd dose of Engerix-B; 1 dose: 01/12/2021 - 2 dose: 02/23/2021; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 38-year-old male patient who received HBV (Engerix B) (batch number 9P9B5, expiry date 7th February 2022) for prophylaxis.   Co-suspect products included HBV (Engerix B) for prophylaxis.   Concomitant products included HEPATITIS B VACCINE (ENGERIX B).   On 23rd February 2021, the patient received the 2nd dose of Engerix B. On an unknown date, the patient received the 3rd dose of Engerix B. On 23rd February 2021, unknown after receiving Engerix B and not applicable after receiving Engerix B, the patient experienced drug dose administration interval too long. On an unknown date, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the drug dose administration interval too long and incomplete course of vaccination were unknown.  Additional details were provided as follows: The age at vaccination was not applicable for 3rd dose. On 12th January 2021, the patient received 1st dose of Engerix B. The patient received 2nd dose of Engerix B later than recommended interval, which led to lengthening of vaccine schedule. The health care practitioner did contact the patient to receive the 3 dose but did not come in, which led to incomplete course of vaccination. The reporter consented to follow up.
pt felt  faint  after given  shot, had pt sit down, feet up, drink water and given  ice compress, after 30 minutes pt left  feeling fine
The area where she received Immunization is pink. It was itching 2 days ago but is not itching anymore.
No reaction until 4 days after vaccination. Lower body, especially legs. Soreness in the calves and back of knees. made walking extremely difficult. Day 5 pain in right leg ceased but concentrated in left leg and knee. I could not walk without standing and stretching out the muscle. On day 7 pain in left calf ceased but walking was difficult. Days 8-9 kept legs up as much as possible because walking caused edema in left ankle and foot. Today is day 10 and I am walking better but ligaments in back of left knee are still tight. Pain is focused only on the front right side of left knee.
they both felt like flu-like symptoms; achy; no appetite; her right arm extremely sore; loss of taste; tired/exhaustion; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (they both felt like flu-like symptoms), PAIN (achy), DECREASED APPETITE (no appetite), PAIN IN EXTREMITY (her right arm extremely sore) and AGEUSIA (loss of taste) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (they both felt like flu-like symptoms), PAIN (achy), DECREASED APPETITE (no appetite), PAIN IN EXTREMITY (her right arm extremely sore), AGEUSIA (loss of taste), FATIGUE (tired/exhaustion), CHILLS (chills) and HEADACHE (headache). The patient was treated with IBUPROFEN (ADVEL) at an unspecified dose and frequency. On 06-Mar-2021, INFLUENZA LIKE ILLNESS (they both felt like flu-like symptoms), PAIN (achy), DECREASED APPETITE (no appetite), PAIN IN EXTREMITY (her right arm extremely sore), AGEUSIA (loss of taste), FATIGUE (tired/exhaustion), CHILLS (chills) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Got the first Pfizer COVID Vaccine and today I tested positive for COVID; Got the first Pfizer COVID Vaccine and today I tested positive for COVID; Congestion; Sore throat; This is a spontaneous report from a contactable consumer reporting for herself. A 26-years-old female patient  received  bnt162b2 (BNT162B2; Lot # EL0140) vaccine , via an unspecified route of administration on an unknown date in Dec2020 at  single dose for Covid-19 immunisation .  The patient medical history was not reported.  There were no concomitant medications.  The patient stated she got the first Pfizer Covid vaccine and on an unknown date in Dec2020 she tested positive for Covid 19, she also experienced nasal congestion and sore throat. The outcome of the events is unknown.